Hospira buprenorphine and labetalol injections (Carpuject units), used in veterinary clinics

Recall announced May 22, 2024 by Hospira Inc, posted by the U.S. Food and Drug Administration (FDA). Reason: Potential packaging defect. It affects dogs, cats, rabbits and small pets and farm animals. The agency has not closed this recall.

Brands
Hospira
Where sold
Distributed nationwide to wholesalers and hospitals from September 2023 through April 2024.
Last updated
November 20, 2026

Products included

Read the official notice. Always compare the codes on your package with the official notice. It is the final word.

Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.

See all pet recalls